ARROWHEAD PHARMACEUTICALS, INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$46.00 million for the 131-month period ending 2014-03-31, per its 10-Q filed 2014-05-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2015-12-14
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2013-09-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2013-03-31 was -$336.00.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2012-12-31 was -$18.00.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2013 was -$354.00.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2012 was -$280.00, a 100.01% decline from fiscal 2011.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2011 was $2.27M.
- ARROWHEAD PHARMACEUTICALS, INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2010 was -$2.65M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 98 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 101 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 104 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 107 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 110 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 113 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 116 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 119 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 122 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 125 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 128 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | -$46.00M 10-Q · filed 2014-05-06 | |||||||||||||||
| 2013-12-31 | -$46.00M 10-Q · filed 2014-02-04 | |||||||||||||||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | $0.00 derived: sum of 2 quarters · filed 2015-12-14 | -$336.00 derived: sum of 3 quarters · filed 2015-12-14 | -$354.00 10-K · filed 2015-12-14 | -$46.00M 10-K · filed 2013-12-18 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | -$336.00 derived: sum of 2 quarters · filed 2014-08-12 | -$354.00 10-Q · filed 2014-08-12 | -$409.00 derived: sum of 4 quarters · filed 2014-11-25 | -$46.00M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | -$336.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-06 | -$354.00 10-Q · filed 2014-05-06 | -$409.00 derived: sum of 3 quarters · filed 2014-11-25 | $268.00 derived: sum of 4 quarters · filed 2014-11-25 | -$46.00M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | -$18.00 10-Q · filed 2014-02-04 | -$73.00 derived: sum of 2 quarters · filed 2014-11-25 | $604.00 derived: sum of 3 quarters · filed 2014-11-25 | $122.00 derived: sum of 4 quarters · filed 2014-11-25 | -$46.00M 10-Q · filed 2013-02-13 | |||||||||||
| 2012-09-30 | -$55.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $622.00 derived: sum of 2 quarters · filed 2014-11-25 | $140.00 derived: sum of 3 quarters · filed 2014-11-25 | -$280.00 10-K · filed 2014-11-25 | -$46.00M 10-K · filed 2012-12-28 | |||||||||||
| 2012-06-30 | $677.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07 | $195.00 derived: sum of 2 quarters · filed 2013-08-07 | -$225.00 10-Q · filed 2013-08-07 | -$580.00 derived: sum of 4 quarters · filed 2013-08-07 | -$46.00M 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | -$482.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | -$902.00 10-Q · filed 2013-05-09 | -$1.26K derived: sum of 3 quarters · filed 2013-05-09 | -$58.22K derived: sum of 4 quarters · filed 2013-05-09 | -$46.00M 10-Q · filed 2012-05-08 | |||||||||||
| 2011-12-31 | -$420.00 10-Q · filed 2013-02-13 | -$775.00 derived: sum of 2 quarters · filed 2013-02-13 | -$57.73K derived: sum of 3 quarters · filed 2013-02-13 | $2.81M derived: sum of 4 quarters · filed 2013-02-13 | -$46.00M 10-Q · filed 2012-02-09 | |||||||||||
| 2011-09-30 | -$355.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | -$57.31K derived: sum of 2 quarters · filed 2012-12-28 | $2.81M derived: sum of 3 quarters · filed 2012-12-28 | $2.27M 10-K · filed 2012-12-28 | -$46.00M 10-Q · filed 2012-08-13 | |||||||||||
| 2011-06-30 | -$56.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-13 | $2.81M derived: sum of 2 quarters · filed 2012-08-13 | $2.27M 10-Q · filed 2012-08-13 | $1.64M derived: sum of 4 quarters · filed 2012-08-13 | -$46.00M 10-Q · filed 2011-08-08 | |||||||||||
| 2011-03-31 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-08 | $2.32M 10-Q · filed 2012-05-08 | $1.69M derived: sum of 3 quarters · filed 2012-05-08 | |||||||||||||
| 2010-12-31 | -$544.34K 10-Q · filed 2012-02-09 | -$1.17M derived: sum of 2 quarters · filed 2012-02-09 | ||||||||||||||
| 2010-09-30 | -$627.88K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | -$2.65M 10-K · filed 2011-12-20 | ||||||||||||||
| 2010-06-30 | -$2.02M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |